2025 annual financial data
Oramed Pharmaceuticals 2025 Operating margin
Oramed Pharmaceuticals 2025 operating margin with verified reported values.
Direct answer
Operating margin was -754.4%.
Operating income was -15,088,000 USD and net income was 64,050,000 USD.
Operating cash flow was -9,145,000 USD.
Get free Oramed Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 2,000,000 USD
- Operating income
- -15,088,000 USD
- Net income
- 64,050,000 USD
- Operating cash flow
- -9,145,000 USD